TipRanks
Go Ultimate55% OFF

GlaxoSmithKline (GS70) Income Statement

GlaxoSmithKline Income Statement

Last quarter (Q3 2026), GlaxoSmithKline's total revenue was $8.82B, an increase of 3.16% from the same quarter last year. In Q3, GlaxoSmithKline's net income was $1.53B. See GlaxoSmithKline’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
$ 32.67B$ 31.38B$ 30.33B$ 29.32B$ 24.70B
$ 23.65B$ 22.33B$ 21.76B$ 19.77B$ 16.53B
$ 15.31B$ 18.31B$ 15.02B$ 13.34B$ 12.18B
Depreciation and Amortization$ 2.31B$ 2.55B$ 2.29B$ 2.15B$ 2.12B
$ 10.40B$ 6.67B$ 9.08B$ 8.60B$ 6.49B
$ 8.34B$ 4.02B$ 6.75B$ 6.43B$ 4.36B
$ -937.00M$ -544.00M$ -681.00M$ -805.00M$ -758.00M
$ 7.40B$ 3.48B$ 6.06B$ 5.63B$ 3.60B
$ 5.72B$ 2.58B$ 4.93B$ 14.96B$ 4.38B
Per Share Metrics
Basic EPS$ 2.82$ 1.26$ 2.44$ 7.44$ 2.74
Diluted EPS$ 2.78$ 1.24$ 2.40$ 7.32$ 2.70
Weighted Average Shares Outstanding2.03B2.04B2.03B2.01B1.60B
Weighted Average Shares Outstanding (Diluted)2.06B2.07B2.06B2.04B1.62B

Currency in GBP

GlaxoSmithKline Earnings and Revenue History

012B24B36B0 %20 %40 %60 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin